Crossmark

How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts

Crossref DOI link: https://doi.org/10.1007/s10461-021-03418-2

Published Online: 2021-08-11

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Milford, Cecilia https://orcid.org/0000-0002-0026-7560
Cavanagh, Tammany

Ralfe, Yolandie

Maphumulo, Virginia

Beksinska, Mags

Smit, Jennifer
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (OPP1032115)

United States Agency for International Development (AID-OAA-A-15–00045)

the Swedish International Development Cooperation Agency (2017/762965–0)
License Information

Text and Data Mining valid from 2021-08-11

Version of Record valid from 2021-08-11
More Information

Article History

Accepted: 30 July 2021

First Online: 11 August 2021

Declarations

:

: The authors declare that there is no conflict of interest.

: This was a sub-study of the ECHO clinical trial, and was approved by the University of the Witwatersrand’s Human Research Ethics Committee (HREC) (Ref: 141112) in October 2017.

: All participants provided written informed consent. Separate consent was obtained for the quantitative and qualitative components, and participants in the FGDs also provided written consent to the audio recording of the discussions.

: Not applicable, individual data/images not used.

Document is current

Any future updates will be listed below